Financials
Financial year 2025
APO-PHARMAN from Alveringem, company number BE0892860848, closed financial year 2025 with a result of € 61,326 after tax. For that financial year APO-PHARMAN recorded a gross margin of € 252,575 and equity of € 422,116. Compared with financial year 2024, the result moved from € 97,475 to € 61,326. The company is profitable. The buffer is growing. Debts are under control. The most recent annual accounts were filed with the National Bank of Belgium on July 22, 2026.
€ 422,116
▲ 17% vs 2024
Assets minus debts, by the books. What is left if everything were sold and paid today.
€ 61,326
▼ 37% vs 2024
Profit after tax over the fiscal year.
€ 479,052
▲ 12% vs 2024
Cash and bank balances on the last day of the fiscal year.
Stays in the company
No dividend for 2025. Retained profit grew to € 272,116.
People and assets in 2025
0.9
Average over the fiscal year, from the social balance sheet.
€ 72,443
▲ 11% vs 2024
Payroll staff only. What the director pays themselves is already netted into the gross margin and is not shown separately in the accounts.
€ 33,582
▲ € 32,201 vs 2024
Book value of vehicles, furniture and equipment.
Debts at end 2025
€ 485,307
▼ 6% vs 2024
€ 58,504 is repaid this year. At this pace the long-term loan is gone in ≈ 8 years.
€ 50,271
▼ 6% vs 2024
Supplier invoices still open on the last day of the fiscal year.
€ 46,513
▼ 6% vs 2024
Taxes, VAT and social contributions still to pay.
| 2022 | 2023 | 2024 | 2025 | Change 2024 → 2025 | |
|---|---|---|---|---|---|
| Gross margin | € 236,179 | € 229,877 | € 274,496 | € 252,575 | ▼ 8% |
| Profit after taxes | € 59,124 | € 80,802 | € 97,475 | € 61,326 | ▼ 37% |
| Equity | € 185,514 | € 266,315 | € 360,791 | € 422,116 | ▲ 17% |
| Total debts | € 1,060,732 | € 979,987 | € 920,659 | € 884,584 | ▼ 4% |
| Cash | € 298,775 | € 354,975 | € 427,332 | € 479,052 | ▲ 12% |
| Land & buildings | € 792,949 | € 729,199 | € 665,990 | € 609,399 | ▼ 8% |
| Retained profit | € 35,514 | € 116,315 | € 210,791 | € 272,116 | ▲ 29% |
| Dividend | € 0 | € 0 | € 3,000 | € 0 | ▼ 100% |
| Bank debt | € 654,815 | € 583,807 | € 514,841 | € 485,307 | ▼ 6% |
| Balance sheet total | € 1,246,246 | € 1,246,303 | € 1,281,450 | € 1,306,700 | ▲ 2% |
| Employees (FTE) | 1.3 | 1.2 | 0.9 | 0.9 |
Key figures of APO-PHARMAN, fiscal years 2022 to 2025, from the annual accounts filed with the National Bank of Belgium.Next annual account (fiscal year 2026) expected before 31 July 2027.
What happened to APO-PHARMAN?
What happened at APO-PHARMAN in recent years, according to the Belgian Official Gazette, the CBE and the National Bank:
- New annual accounts for financial year 2025: profit of € 61,326 (▼ 37% vs 2024). Source: NBB ↗
- Start of the company according to the CBE. KBO
- New establishment in Alveringem. KBO
In short
From € 59,124 profit in 2022 to € 61,326 profit in 2025.
Paid € 53,268 in corporate taxes since 2022.
Best year ever: 2024, with € 97,475 profit.
On average € 191,600 of value added per employee in 2023.
Management
Behind APO-PHARMAN is Julie Plasman.
Directors
According to the 2025 annual accounts
Julie Plasman
Manager
Establishments
Establishment units
Physical locations of this company
Dorp 31
8690 Alveringem
Who else lives here?
A building full of entrepreneurs or one very busy letterbox? Another 2 companies are registered at this address.
All companies at this address →What is an establishment unit? An establishment unit is a geographically identifiable place where activities of the enterprise are carried out.
Details
- Company number
- 0892.860.848
- VAT number
- BE 0892.860.848
- Registered office
- Dorp 31, 8690 Alveringem
- Names & denominations
- APO-PHARMAN
- Enterprise type
- Rechtspersoon
- Legal form
- Private limited company
- Legal situation
- Normale toestand
- Start date
- 17 October 2007
- Peppol
- Active · Active since 19 Dec 2025
- Activities · NACE
Detailhandel in farmaceutische producten